JANSSEN PHARMACEUTICALS
Janssen Pharmaceuticals reduces the risk of stroke and blood clots in adults and has a medical condition called atrial fibrillation. That is caused by a heart valve problem. The atrial fibrillation, part of the heart does not beat the way it should. They can lead to the formation of blood clots, which can travel to the brain, causing a stroke, or to other parts of the body, treat blood clots in the veins of a legs reduce the risk of blood clots from happening again in adults.
JANSSEN PHARMACEUTICALS
Industry:
Health Care Hospital Medical Personal Health
Address:
Titusville, New Jersey, United States
Country:
United States
Website Url:
http://www.xarelto-us.com
Status:
Active
Contact:
1 800 526 7736
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Drupal Brightcove DataPipe
Similar Organizations
Evanesc Therapeutics
Evanesc therapeutics provides cancer treatment .
Hope Health Systems
Hope Health Systems is a mental health care.
MedLocker
Pharmaceuticals & Public Health Data Reports
Paracelsus clinics
Paracelsus clinics is a health care platform.
Pharmajani S.r.l
Pharmajani S.r.l is a
The Skinsheet
The Skinsheet is a hospital and health care.
Official Site Inspections
http://www.xarelto-us.com Semrush global rank: 932.59 K Semrush visits lastest month: 38.58 K
- Host name: 104.18.34.26
- IP address: 104.18.34.26
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Janssen Pharmaceuticals"
XARELTO® (rivaroxaban) Healthcare Professional (HCP) Website
XARELTO® (rivaroxaban) Official Healthcare Professional Website. See full Prescribing & Safety Information, including Boxed Warnings.See details»
Contact Us | XARELTO® (rivaroxaban): A Prescription …
If you prefer to correspond with us via regular mail, or have inquiries regarding vendor opportunities or marketing/product suggestions, please use the following address: Janssen Scientific Affairs Medical Information Center PO Box 200 …See details»
Contact us - Xarelto Global
Information about Xarelto® (Rivaroxaban), stroke prevention in atrial fibrillation, treatment and prevention of VTE (DVT/PE) and secondary prevention after ACS.See details»
Sitemap | XARELTO® (rivaroxaban) Official Patient Website
XARELTO® (rivaroxaban) Official Patient Website. See full Prescribing & Safety Info, including Boxed Warnings.See details»
Resources | XARELTO® (rivaroxaban) HCP
XARELTO® (rivaroxaban) Official Healthcare Professional Website. See full Prescribing & Safety Information, including Boxed Warnings.See details»
Patient Access | XARELTO® (rivaroxaban) HCP
Eligible patients receive a free 30-day trial supply of XARELTO® with a valid signed 30-day prescription for any XARELTO® dose other than 10-mg tablet or 1 mg/mL oral suspension. The XARELTO withMe Trial Offer can be used with …See details»
Xarelto® – Resources and Utilities - Xarelto Global
This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to …See details»
U.S. FDA approves Bayer’s Xarelto® for patients with coronary or ...
Oct 12, 2018 Xarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery …See details»
Paying for XARELTO® | Janssen CarePath
Increased risk of bleeding. XARELTO ® can cause bleeding which can be serious and may lead to death. This is because XARELTO ® is a blood thinner medicine (anticoagulant) that lowers blood clotting. During treatment with XARELTO ® …See details»
Savings and Support | XARELTO® (rivaroxaban)
XARELTO withMe Trial Offer. A free 30-day trial offer is available for eligible patients to help you become familiar with XARELTO ®.. Eligible patients receive a free 30-day trial supply of XARELTO ® with a valid signed 30-day prescription …See details»
Xarelto® (Rivaroxaban) - Tailored Protection for Your Cardio …
This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to …See details»
For Patients & Caregivers with Atrial Fibrillation - Xarelto Global
This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to …See details»
Xarelto Dosing Guide
4 Mode of Action 1,3 aChange from baseline (ng/ml enoxaparin).bEnoxaparin 40 mg. cXarelto 10 mg. Xarelto® is a fast-acting, oral, direct factor Xa inhibitor that provides protection for your …See details»
What is XARELTO? - jnjmedicalconnect.com
Nov 19, 2024 What is XARELTO? XARELTO is a prescription medicine used to 1: reduce the risk of stroke and blood clots in adults who have a medical condition called atrial fibrillation that is not caused by a heart valve problem. With atrial fibrillation, part of the heart does not beat the way it …See details»
Important Safety Information | XARELTO® (rivaroxaban)
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Janssen Pharmaceuticals, Inc., at 1-800 …See details»
XARELTO- rivaroxaban tablet, film coated - fda.report
XARELTO for the treatment of DVT and/or PE was studied in EINSTEIN DVT [NCT00440193] and EINSTEIN PE [NCT00439777], multi-national, open-label, non-inferiority studies comparing XARELTO (at an initial dose of 15 mg twice daily with food for the first three weeks, followed by XARELTO 20 mg once daily with food) to enoxaparin 1 mg/kg twice daily for at least five days …See details»
DailyMed - XARELTO- rivaroxaban tablet, film coated XARELTO ...
XARELTO for the treatment of DVT and/or PE was studied in EINSTEIN DVT [NCT00440193] and EINSTEIN PE [NCT00439777], multi-national, open-label, non-inferiority studies …See details»
XARELTO® (rivaroxaban) | Official Patient Website
Find XARELTO® cost support and insurance information, including personalized support with XARELTO withMe. See full Prescribing & Safety Info, including Boxed Warnings.See details»
XARELTO - How is XARELTO supplied? - Janssen Science
Summary. XARELTO is supplied in the United States as a tablet (2.5-mg, 10-mg, 15-mg, and 20- mg) and granules in an amber glass bottle (1 mg/mL oral suspension once reconstituted). 1 …See details»
Xarelto® - Resources
This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to …See details»